NSE filing, NSE: RELIGARE. Summary written from the filing by ALFA Finder's alert engine.
Religare Enterprises Ltd: key numbers
- Share price
- ₹224.19
- Market cap
- ₹7,729 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- 333.2×Sector 19.4×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Debt & Borrowing: ₹150 Cr
Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.
- Value
- ₹150.0 Cr
Religare Enterprises Management Change
Religare Enterprises appointed Ms. Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer w.e.f. October 31, 2026. She was designated as a Key Managerial Personnel.
Religare Enterprises Other Announcement
Religare Enterprises has filed its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI Regulation 31(1)(b).
Religare Enterprises Employee Stock Options
Religare Enterprises allotted 22,000 equity shares upon exercise of employee stock options. This allotment increases the company's issued and paid-up equity capital.
Religare Enterprises Management Change
Religare disclosed Mr. Gaurav Sharma as CTO of subsidiary Religare Finvest, effective October 6, 2026. He brings ~30 years of fintech experience from IIFL and L&T Financial.
Religare Enterprises Annual General Meeting
Religare Enterprises Limited held its 42nd Annual General Meeting on September 24, 2026, where members adopted financial statements and approved the re-designation of Mr. Arjun Lamba.
Other credit rating announcements
All →Mahindra & Mahindra Credit Rating
CARE Ratings reaffirmed Mahindra & Mahindra's bank facility ratings at CARE AAA; Stable / CARE A1+. The action covers existing facilities and raises no new debt.
UCO Bank Credit Rating
UCO Bank disclosed S&P Global Ratings assigning it a BBB long-term and A-2 short-term issuer rating, with a stable outlook. The rating rationale dated November 4, 2026 is enclosed.
Chaman Lal Setia Exports Credit Rating
Chaman Lal Setia Exports Ltd disclosed that CRISIL reaffirmed its CRISIL A+/Stable long-term rating on Rs. 350 Crore of bank loan facilities. The reaffirmation confirms unchanged credit quality, with no rating upgrade or downgrade.
Purple United Sales Credit Rating
Purple United Sales' credit rating from Crisil was reaffirmed at BBB-/Stable on Rs.175 Crore of bank facilities. The rated facilities were enhanced from Rs.100 Crore.
Pioneer Investcorp Credit Rating
Pioneer Investcorp received an IVR A2+ rating from Informics Valuation and Rating on November 3, 2026. The rating covers its INR 25 Crore commercial paper.
Sahajanand Medical Technologies Credit Rating
CRISIL has upgraded Sahajanand Medical Technologies' long-term bank facility rating to CRISIL A-/Stable from BBB+/Stable. The upgrade reflects improved business risk, growing scale, and sustained profitability across its global stent manufacturing operations.
- Value
- ₹300.0 Cr